Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 845.20
-31.00 (-3.54%)
Oct 21, 2026, 3:29 PM IST
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 165.26 billion as of October 21, 2026. Its market cap has increased by 133.96% in one year.
Market Cap
165.26B
Enterprise Value
171.41B
Revenue
16.83B
Global Rank
n/a
Country Rank
n/a
PE Ratio
57.62
ChartMarket Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 165.26B, an increase of 366,348.06%. That is a compound annual growth rate of 35.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 165.26B | 163.06% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 335.09B |
| Wockhardt | 309.76B |
| Piramal Pharma | 258.46B |
| Cohance Lifesciences | 175.11B |
| Alivus Life Sciences | 155.71B |
| Eris Lifesciences | 155.44B |
| Alembic Pharmaceuticals | 155.35B |
| NATCO Pharma | 143.83B |